Correlation Between Cullinan Oncology and Dice Molecules

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Cullinan Oncology and Dice Molecules at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Cullinan Oncology and Dice Molecules into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Cullinan Oncology LLC and Dice Molecules Holdings, you can compare the effects of market volatilities on Cullinan Oncology and Dice Molecules and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Cullinan Oncology with a short position of Dice Molecules. Check out your portfolio center. Please also check ongoing floating volatility patterns of Cullinan Oncology and Dice Molecules.

Diversification Opportunities for Cullinan Oncology and Dice Molecules

-0.86
  Correlation Coefficient

Pay attention - limited upside

The 3 months correlation between Cullinan and Dice is -0.86. Overlapping area represents the amount of risk that can be diversified away by holding Cullinan Oncology LLC and Dice Molecules Holdings in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Dice Molecules Holdings and Cullinan Oncology is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Cullinan Oncology LLC are associated (or correlated) with Dice Molecules. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Dice Molecules Holdings has no effect on the direction of Cullinan Oncology i.e., Cullinan Oncology and Dice Molecules go up and down completely randomly.

Pair Corralation between Cullinan Oncology and Dice Molecules

If you would invest  4,697  in Dice Molecules Holdings on September 28, 2024 and sell it today you would earn a total of  0.00  from holding Dice Molecules Holdings or generate 0.0% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthSignificant
Accuracy1.61%
ValuesDaily Returns

Cullinan Oncology LLC  vs.  Dice Molecules Holdings

 Performance 
       Timeline  
Cullinan Oncology LLC 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Cullinan Oncology LLC has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of unsteady performance in the last few months, the Stock's technical and fundamental indicators remain very healthy which may send shares a bit higher in January 2025. The recent disarray may also be a sign of long period up-swing for the firm investors.
Dice Molecules Holdings 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Dice Molecules Holdings has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of rather sound fundamental indicators, Dice Molecules is not utilizing all of its potentials. The latest stock price tumult, may contribute to shorter-term losses for the shareholders.

Cullinan Oncology and Dice Molecules Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Cullinan Oncology and Dice Molecules

The main advantage of trading using opposite Cullinan Oncology and Dice Molecules positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Cullinan Oncology position performs unexpectedly, Dice Molecules can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Dice Molecules will offset losses from the drop in Dice Molecules' long position.
The idea behind Cullinan Oncology LLC and Dice Molecules Holdings pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Center module to all portfolio management and optimization tools to improve performance of your portfolios.

Other Complementary Tools

Portfolio File Import
Quickly import all of your third-party portfolios from your local drive in csv format
Odds Of Bankruptcy
Get analysis of equity chance of financial distress in the next 2 years
Portfolio Dashboard
Portfolio dashboard that provides centralized access to all your investments
Instant Ratings
Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance
Insider Screener
Find insiders across different sectors to evaluate their impact on performance